Hana Pharm Co Ltd
KRX:293480
Hana Pharm Co Ltd
Cost of Revenue
Hana Pharm Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hana Pharm Co Ltd
KRX:293480
|
Cost of Revenue
-₩84B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Cost of Revenue
-₩1.4T
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-7%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Cost of Revenue
-₩43.1B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-142%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Cost of Revenue
-₩678.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Cost of Revenue
-₩111.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Cost of Revenue
-₩323.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-31%
|
|
Hana Pharm Co Ltd
Glance View
Hana Pharm Co., Ltd. engages in the research, development, and manufacture of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 657 full-time employees. The company went IPO on 2018-10-02. The company’s main products include cardiovascular drugs involves hypertension and hyperlipidemia medicines, as well as blood circulation improvement drugs; analgesics for severe pain and anesthetics for surgery and sedation; as well as gastrointestinal drugs such as peptic ulcer treatment and antispasmodics. The firm also provides antibiotics, dermatology analgesics, antipyretics and anti-inflammatory drugs.
See Also
What is Hana Pharm Co Ltd's Cost of Revenue?
Cost of Revenue
-84B
KRW
Based on the financial report for Dec 31, 2024, Hana Pharm Co Ltd's Cost of Revenue amounts to -84B KRW.
What is Hana Pharm Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-8%
Over the last year, the Cost of Revenue growth was 1%. The average annual Cost of Revenue growth rates for Hana Pharm Co Ltd have been -9% over the past three years , -8% over the past five years .
You don't have any saved screeners yet